Skip to main content
Log in

Gaps in funding of high cost drugs for rare diseases in England

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. National Institute for Health and Care Excellence

Reference

  • Sanghvi S, et al. Are high cost drug funding mechanisms fit for purpose? - A retrospective study of Individual Funding Requests in an NHS tertiary hospital. British Journal of Clinical Pharmacology : 5 Jun 2020. Available from: URL: http://doi.org/10.1111/bcp.14409

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaps in funding of high cost drugs for rare diseases in England. PharmacoEcon Outcomes News 856, 17 (2020). https://doi.org/10.1007/s40274-020-6917-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6917-z

Navigation